Application no. and date | 09822828.1 (espacenet) (Federated) (European Patent Register), 20091024 | Patent/reg. no. and date | DK/EP 2358379, 20151216 | Publication date | 20110824 | Priority no. and date | US 108137 P, 20081024, US 108110 P, 20081024, US 108134 P, 20081024, US 108168 P, 20081024, US 108112 P, 20081024, US 162109 P, 20090320 | EP pub. no. and date |
EP 2358379 20110824 | Effective date | | Applicant/owner | Cempra Pharmaceuticals, Inc., 6320 Quadrangle Drive, Suite 360
Chapel Hill, NC 27517, US | Applicant ref. no. | T5126DK00 | Inventor | FERNANDES, Prabhavathi, B., 114 Milton Avenue
Chapel Hill, NC 27514, US | Representative | Orsnes Patent ApS, Sentvedvej 23, 5853 Ørbæk, DK | Opponent | | IPC Class | A61K 31/70 (2006.01) , A61K 31/7048 (2006.01) , A61K 31/7052 (2006.01) , A61P 31/04 (2006.01) | Title | BIOFORSVAR VED ANVENDELSE AF TRIAZOLHOLDIGE MACROLIDER | Int. application no. | US2009061978 | Int. publication no. | WO2010048601 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|